Alpha 1-antitrypsin deficiency primary prevention: Difference between revisions

Jump to navigation Jump to search
Line 9: Line 9:


==Primary Prevention==
==Primary Prevention==
Effective measures for the primary prevention of alpha 1-antitrypsin deficiency include:
Effective measures for the primary prevention of alpha 1-antitrypsin deficiency include:<ref name="pmid16236846">{{cite journal |vauthors=Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C |title=Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem |journal=Chest |volume=128 |issue=4 |pages=1989–94 |year=2005 |pmid=16236846 |doi=10.1378/chest.128.4.1989 |url=}}</ref>
*Vaccination against hepatitis A and B is recommended to decrease the risk of liver disease.
*Vaccination against hepatitis A and B is recommended to decrease the risk of liver disease.



Revision as of 01:18, 16 December 2017

Alpha 1-antitrypsin deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Alpha 1-antitrypsin deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alpha 1-antitrypsin deficiency primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alpha 1-antitrypsin deficiency primary prevention

CDC on Alpha 1-antitrypsin deficiency primary prevention

Alpha 1-antitrypsin deficiency primary prevention in the news

Blogs on Alpha 1-antitrypsin deficiency primary prevention

Directions to Hospitals Treating Alpha 1-antitrypsin deficiency

Risk calculators and risk factors for Alpha 1-antitrypsin deficiency primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Effective measures for the primary prevention of alpha 1-antitrypsin deficiency includes vaccination against hepatitis A and B is recommended to decrease the risk of liver disease.

Primary Prevention

Effective measures for the primary prevention of alpha 1-antitrypsin deficiency include:[1]

  • Vaccination against hepatitis A and B is recommended to decrease the risk of liver disease.

References

  1. Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C (2005). "Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem". Chest. 128 (4): 1989–94. doi:10.1378/chest.128.4.1989. PMID 16236846.


Template:WikiDoc Sources